Influence of drying processes on the structures, morphology and in vitro release profiles of risperidone-loaded PLGA microspheres

References

• Alexis, F., 2005. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]. Polymer international, 54 (1), 36–46.
   Web of Science ®Google Scholar
• Andhariya, J.V., Choi, S. and Wang, Y., 2017. Accelerated in vitro release testing method for naltrexone loaded PLGA microspheres. International journal of pharmaceutics, 520 (1–2), 79–85.
   PubMed Web of Science ®Google Scholar
• Andhariya, J.V., et al., 2017. Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres. Journal of controlled release, 255, 27–35.
   PubMed Web of Science ®Google Scholar
• Anselmo, A.C. and Mitragotri, S., 2014. An overview of clinical and commercial impact of drug delivery systems. Journal of controlled release, 190, 15–28.
   PubMed Web of Science ®Google Scholar
• Blasi, P., et al., 2005. Plasticizing effect of water on poly(lactide-co-glycolide). Journal of controlled release, 108 (1), 1–9.
   PubMed Web of Science ®Google Scholar
• Busatto, C., et al., 2018. Effect of particle size, polydispersity and polymer degradation on progesterone release from PLGA microparticles: experimental and mathematical modeling. International journal of pharmaceutics, 536 (1), 360–369.
   PubMed Web of Science ®Google Scholar
• Cai, C., et al., 2009. Influence of morphology and drug distribution on the release process of FITC-dextran-loaded microspheres prepared with different types of PLGA. Journal of microencapsulation, 26 (4), 334–345.
   PubMed Web of Science ®Google Scholar
• Chaisri, W., et al., 2011. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters. Colloids and surfaces. B, Biointerfaces, 84 (2), 508–514.
   PubMed Web of Science ®Google Scholar
• Chaurasia, S., et al., 2017. 3-month parenteral PLGA microsphere formulations of risperidone: fabrication, characterization and neuropharmacological assessments. Materials science and engineering C: materials, 75, 1496–1505.
   PubMed Web of Science ®Google Scholar
• Deshmukh, R., Wagh, P., and Naik, J., 2016. Solvent evaporation and spray drying technique for micro- and nanospheres/particles preparation: a review. Drying technology, 34 (15), 1758–1772.
   Web of Science ®Google Scholar
• Diwan, M. and Park, T.G., 2001. Pegylation enhances protein stability during encapsulation in PLGA microspheres. Journal of controlled release, 73 (2–3), 233–244.
   PubMed Web of Science ®Google Scholar
• D’Souza, S., et al., 2014. In vitro-in vivo correlation from lactide-co-glycolide polymeric dosage forms. Progress in biomaterials, 3 (2–4), 131–142.
   PubMedGoogle Scholar
• Faisant, N., Siepmann, J., and Benoit, J.P., 2002. PLGA-based microparticles elucidation of mechanisms and a new simple mathematical model quantifying drug release. European journal of pharmaceutical sciences, 15 (4), 355–366.
   PubMed Web of Science ®Google Scholar
• Fu, J., et al., 2017. Preparation and physicochemical characterization of T-OA PLGA microspheres. Chinese journal of natural medicines, 15 (12), 912–916.
   PubMed Web of Science ®Google Scholar
• Gaignaux, A., et al., 2012. Development and evaluation of sustained-release clonidine-loaded PLGA microparticles. International journal of pharmaceutics, 437 (1–2), 20–28.
   PubMed Web of Science ®Google Scholar
• Gu, B., et al., 2016. Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere/PVA hydrogel composites. Journal of controlled release, 228, 170–178.
   PubMed Web of Science ®Google Scholar
• Havel, H.A., 2016. Where are the nanodrugs? An industry perspective on development of drug products containing nanomaterials. AAPS journal, 18 (6), 1–3.
   PubMed Web of Science ®Google Scholar
• Hu, Z., et al., 2011. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres. Colloids and surfaces. B Biointerfaces, 86 (1), 206–211.
   PubMed Web of Science ®Google Scholar
• Jain, A., et al., 2016. Injectable formulations of poly(lactic acid) and its copolymers in clinical use. Advanced drug delivery reviews, 107, 213–227.
   PubMed Web of Science ®Google Scholar
• Kim, T.H. and Park, T.G., 2004. Critical effect of freezing/freeze-drying on sustained release of FITC-dextran encapsulated within PLGA microspheres. International journal of pharmaceutics, 271 (1–2), 207–214.
   PubMed Web of Science ®Google Scholar
• Lv, H., et al., 2015. Effect of the drying process on the preparation of porous silica microspheres. Chemical engineering sciences., 135, 285–293.
   Web of Science ®Google Scholar
• Lyons, S. L., Ramstack, J. M., and Wright, S. G., 2001. Preparation of microparticles having a selected release profile. United States Patent 6194006, 27 February.
   Google Scholar
• Makadia, H.K. and Siegel, S.J., 2011. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers, 3 (3), 1377–1397.
   PubMed Web of Science ®Google Scholar
• Mao, S., et al., 2007. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. International journal of pharmaceutics, 334 (1–2), 137–148.
   PubMed Web of Science ®Google Scholar
• Mao, S., et al., 2008. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. European journal of pharmaceutics and biopharmaceutics, 68 (2), 214–223.
   PubMed Web of Science ®Google Scholar
• Mao, S., et al., 2012. Recent advances in polymeric microspheres for parenteral drug delivery-part 1. Expert opinion on drug delivery, 9 (9), 1161–1176.
   PubMed Web of Science ®Google Scholar
• Marquette, S., et al., 2014. Encapsulation of immunoglobulin G by solid-in-oil-in-water: effect of process parameters on microsphere properties. European journal of pharmaceutics and biopharmaceutics, 86 (3), 393–403.
   PubMed Web of Science ®Google Scholar
• Mcevoy, J.P., 2006. Risks versus benefits of different types of long-acting injectable antipsychotics. Journal of clinical psychiatry, 67 (5), 15–18.
   PubMed Web of Science ®Google Scholar
• Mi, F.L., et al., 2002. Chitin/PLGA blend microspheres as a biodegradable drug-delivery system: phase-separation, degradation and release behavior. Biomaterials, 23 (15), 3257–3267.
   PubMed Web of Science ®Google Scholar
• Nasrallah, H.A., 2007. The case for long-acting antipsychotic agents in the post-CATIE era. Acta psychiatrica scandinavica, 115 (4), 260–267.
   PubMed Web of Science ®Google Scholar
• Rawat, A. and Burgess, D.J., 2010. Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics. International journal of pharmaceutics, 394 (1–2), 99–105.
   PubMed Web of Science ®Google Scholar
• Shahzamani, M., et al., 2017. Effect of drying method on the structure and porous texture of silica-polybutadiene hybrid gels: supercritical vs. ambient pressure drying. Journal of non-crystalline solids, 460, 119–124.
   Web of Science ®Google Scholar
• Shang, Q., et al., 2018. In vitro evaluation of sustained release of RIS-loaded microspheres fabricated from different viscosity of PLGA polymers. Polymers for advanced technologies, 29 (1), 384–393.
   Web of Science ®Google Scholar
• Sharma, N., Madan, P., and Lin, S., 2016. Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant study. Asian journal of pharmaceutical sciences, 11 (3), 404–416.
   Web of Science ®Google Scholar
• Shen, J. and Burgess, D.J., 2015. In vitro-in vivo correlation for complex non-oral drug products: where do we stand? Journal of controlled release, 219, 644–651.
   PubMed Web of Science ®Google Scholar
• Shen, J., et al., 2015. In vitro-in vivo correlation of parenteral risperidone polymeric microspheres. Journal of controlled release, 218, 2–12.
   PubMed Web of Science ®Google Scholar
• Shen, J., et al., 2016. A reproducible accelerated in vitro release testing method for PLGA microspheres. International journal of pharmaceutics, 498 (1–2), 274–282.
   PubMed Web of Science ®Google Scholar
• Siepmann, J., et al., 2004. Effect of the size of biodegradable microparticles on drug release: experiment and theory. Journal of controlled release, 96 (1), 123–134.
   PubMed Web of Science ®Google Scholar
• Varde, N.K. and Pack, D.W., 2004. Microspheres for controlled release drug delivery. Expert opinion on biological therapy, 4 (1), 35–51.
   PubMed Web of Science ®Google Scholar
• Velligan, D.L., et al., 2009. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. Journal of clinical psychiatry, 70 (4), 47–48.
   Google Scholar
• Wright, J.C. and Burgess, D.J., 2012. Long acting injections and implants: microsphere technologies. Springer, 167–194.
   Google Scholar
• Xiaoqin, H., et al., 2018. An accelerated release method of risperidone loaded PLGA microspheres with good IVIVC. Current drug delivery, 15 (1), 87–96.
   PubMed Web of Science ®Google Scholar
• Xu, F., et al., 2014. Effects of drying methods on the preparation of dexamethasone-loaded chitosan microspheres. Biomedical materials (Bristol, England), 9 (5), 055003.
   PubMed Web of Science ®Google Scholar
• Yang, Y.Y., Chia, H.H., and Chung, T.S., 2000. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Journal of controlled release, 69 (1), 81–96.
   PubMed Web of Science ®Google Scholar
• Zolnik, B.S., Leary, P.E., and Burgess, D.J., 2006. Elevated temperature accelerated release testing of PLGA microspheres. Journal of controlled release, 112 (3), 293–300.
   PubMed Web of Science ®Google Scholar